COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01519791
Brief Title: A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis (C-early)

First Submitted : January 19, 2012
First Submitted that Met QC Criteria : January 24, 2012
First Posted : January 27, 2012 (Estimate)

Results First Submitted : July 8, 2015
Results First Submitted that Met QC Criteria : August 19, 2015
Results First Posted : September 22, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : July 4, 2018
Last Update Posted : July 31, 2018